Viva Biotech Holdings
1873.HK News Today: Stay Updated with the Latest Viva Biotech Holdings News in Real Time
Find 1873.HK news now at Meyka AI. Stay informed with the latest Viva Biotech Holdings stocks updates, including price news, market analysis, and expert insights.
S63.SI stock S$10.99 intraday (02 Apr 2026): AI stocks angle for traders
S63.SI stock intraday update: S$10.99, PE 74.00, Meyka AI forecast S$13.37 (21.65% upside).
Jefferies Maintains Buy for CTMX (CytomX Therapeutics) March 18, 2026
Jefferies maintained Buy on CTMX March 18, 2026. Read CTMX analyst rating, $16 PT, and Meyka AI grade B+
^GSPC Today: April 2 — Trump’s NATO Exit Talk Lifts Risk Premiums
Trump NATO withdrawal talk lifts risk premia. What it means for NATO Article 5 credibility, S&P 500 today, and Australian portfolios amid rising geopolitical risk markets.
-47% intraday 02 Apr 2026: Creative China 8368.HK HKSE 91.98M vol tests support
8368.HK stock falls 47% intraday on 02 Apr 2026 with **91.98M** volume; short-term pressure and model forecasts signal downside.
Macquarie Maintains Outperform on GDS (GDS Holdings Limited) March 18, 2026
Macquarie and Morgan Stanley maintained ratings on GDS. Read our GDS analyst rating analysis and price target update.
4488.T AI inside Inc. JPX up 4.08% intraday 02 Apr 2026: watch JPY 2,200 support
Intraday look at 4488.T stock at JPY 2,295.00 on 02 Apr 2026 with Meyka AI forecast and trading levels
April 02: Singapore Defamation Ruling Puts Platform Liability in Focus
Singapore’s High Court orders S$420,000 against toc terry xu, sharpening focus on Singapore defamation law and platform liability. What this means for media regulation and investors.
E27.SI The Place Holdings (SES) +100% pre-market 02 Apr 2026: volume spike
E27.SI stock jumps pre-market to SGD 0.004 on heavy trading. Quick analysis, Meyka AI forecast and price targets for investors.
UU.L Stock Today: Citywire Expert View Puts Utility in Focus – April 01
United Utilities in focus after Citywire Expert View. What UU.L stock investors in the UK should watch now: regulation, capex, income case, and near-term catalysts.